Treatment of susceptible bacterial infections.
A penicillin-class antibiotic combined with clavulanic acid to treat susceptible bacterial infections. The 250/125-mg strength is an established co-amoxiclav tablet strength.
Treatment of susceptible bacterial infections.
Certain respiratory, ear, skin/soft-tissue, urinary and other bacterial infections where susceptible organisms are involved.
Take exactly as prescribed, preferably at the start of a meal to improve clavulanate absorption and reduce gastrointestinal intolerance
Diarrhoea, nausea, vomiting, abdominal discomfort and skin rash. Serious allergic reactions and liver-related adverse effects can occur.
Store at or below 25°C in a dry place, protected from moisture and light
Product information is provided for professional and informational purposes. Please refer to the approved product labeling and applicable professional guidance for appropriate use.